Abstract
OBJECTIVE:To assess the efficacy and safety of Neiguan(PC6)acupoint acustimulation in preventing chemotherapy-induced nausea and vomiting(CINV),especially for patients with guideline-inconsistent CINV prophylaxis(GICP)due to personal reasonsMETHODS:From January 2021 to December 2021,373 patients suffered from solid malignancy were recruited according to the inclusion criteria.Complete response(no emesis and no rescue medication use)rate during the overall phase(0-120 h of each chemo-cycle)was the primary assessment of CINV control.The Functional Living Index-Emesis(FLIE)questionnaire was investigated among these patients as a secondary'quality of life'objective to assess the impact of CINV on patients'daily life by recording score of nausea and vomiting.RESULTS:With acustimulation of Neiguan(PC6)acupuncture point through a portable,noninvasive and user-friendly device,in terms of complete response rate and scores in nausea/vomiting by FLIE questionnaire,patients achieve a better outcome in highly emetogenic chemotherapy(HEC)induced CINV,especially GICP subgroup.Meanwhile,analysis also demonstrated this tendency existed in other patients with HEC/GCCP(guideline consistent CINV prophylaxis)and moderate emetogenic chemotherapy,although the difference was not significant.CONCLUSION:Considering advantages of Neiguan(PC6)acustimulation such as noninvasive,covered by medical insurance and few side effects,we believe it would be an ideal auxiliary tool in CINV control,especially in patients who receive highly emetogenic chemo-protocol and are reluctant to GCCP for economic reasons.
基金项目
National and Natural Science Foundation of China(81972521)
NETL
NSTL
万方数据